Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-002479

Chief Discovery/Trans Medicine sold 13,803 shares at $37.40 ($516,232)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamilton James C Chief Discovery/Trans Medicine 2023-01-05 Sale −7,230 $37.40 $270,402 198,057 D
Hamilton James C Chief Discovery/Trans Medicine 2023-01-05 Sale −6,573 $37.40 $245,830 191,484 D
Open-market sales · 13,803 sh · avg $37.40 · $516,232
Loading xslF345X03/doc4.xml…